Related Experiment Video
Updated: May 13, 2025

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Evaluating the Cost-Effectiveness of Chlorhexidine-Coated vs. Standard Peripheral Insertion Central Catheters in
Jia Xu1, Hossein Zare1, Herng-Chia Chiu2
1Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21202, USA.
Insights
Chlorhexidine-coated (AGBA) peripheral insertion central catheters (PICCs) are more cost-effective than standard PICCs for hematologic patients. AGBA PICCs reduce costs and improve quality-adjusted life years (QALYs), offering significant healthcare savings.
Area of Science:
- Health Economics
- Medical Devices
- Oncology
Background:
- Catheter-related complications pose significant risks for patients undergoing chemotherapy.
- Peripheral insertion central catheters (PICCs) are commonly used in hematologic disease management.
- Assessing the cost-effectiveness of advanced medical devices is crucial for optimizing healthcare resource allocation.
Purpose of the Study:
- To evaluate the cost-effectiveness of chlorhexidine-coated (AGBA) PICCs compared to standard PICCs.
- To determine the economic impact of using AGBA PICCs in patients with hematologic diseases.
- To analyze the impact on quality-adjusted life years (QALYs) and healthcare costs.
Main Methods:
- A decision tree health economic model was utilized.
- Data on quality-adjusted life years (QALYs), complication rates, and costs were derived from a randomized controlled trial and literature.
- Incremental cost-effectiveness ratio (ICER) and sensitivity analyses were performed against willingness-to-pay (WTP) thresholds.
Main Results:
- AGBA PICCs demonstrated a cost saving of RMB 2291.10 (USD 428.44) per patient compared to standard PICCs.
- AGBA PICCs were associated with an increase of 0.05 QALYs over 90 days.
- The incremental cost-effectiveness ratio (ICER) for AGBA PICCs was RMB 4271.31 (USD 629.96).
Conclusions:
- AGBA PICCs are a cost-effective intervention for managing catheter-related complications in hematologic patients.
- Sensitivity analyses confirmed the robustness of the findings, supporting AGBA PICCs' economic benefits.
- Adoption of AGBA PICCs in routine chemotherapy can lead to substantial healthcare savings over a one-year period.
Background/Objectives:
This study was conducted to assess the cost-effectiveness of chlorhexidine-coated (AGBA) peripheral insertion central catheters (PICCs) versus standard PICCs for managing catheter-related complications among patients with hematologic disease.
Methods:
A decision tree health economic model was developed, incorporating quality-adjusted life years (QALYs) derived from the literature, as well as complication rates and per-patient costs from a randomized controlled trial. The base case incremental cost-effectiveness ratio (ICER) was assessed against established willingness to pay (WTP) thresholds. One-way sensitivity analyses were conducted to address assumptions and uncertainties.
Results:
The mean healthcare cost per patient of standard PICCs was RMB 21,987.32 (USD 3242.82, at an average exchange rate of RMB 678.03 = USD 100), affecting 0.68 QALYs in 90 days. The mean healthcare cost per patient of AGBA PICCs was RMB 19,696.23 (USD 2904.92), affecting 0.73 QALYs in 90 days, thus resulting in a saving of RMB 2291.10 (USD 428.44). After the model simulation, standard PICCs resulted in a reduction of 0.05 QALYs. The ICER for AGBA PICCs compared with standard PICCs was consistently centered at RMB 4271.31 (USD 629.96).
Conclusions:
one-way sensitivity analyses of cost-effectiveness versus WTP confirmed the robustness of the model across various parameter changes, indicating that AGBA PICCs could provide significant healthcare savings over a 1-year period when adopted in routine chemotherapy treatment for patients with hematologic disease.
More Related Videos
Related Concept Videos
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Hand hygiene
Hand washing...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

